Jim Simons Uro Gen Pharma Ltd. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Renaissance Technologies LLC holds 90,600 shares of URGN stock, worth $448,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,600

Previous 138,200 34.44%

Holding current value

$448,470

Previous $1.47 Million 31.88%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$9.27 - $12.13 $441,252 - $577,388	-47,600 Reduced 34.44%	90,600 $1 Million
Q4 2024 Feb 13, 2025	BUY	$10.52 - $13.11 $1.45 Million - $1.81 Million	138,200 New	138,200 $1.47 Million
Q4 2023 Feb 13, 2024	SELL	$10.87 - $15.93 $750,030 - $1.1 Million	-69,000 Reduced 43.04%	91,300 $1.37 Million
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $762,892 - $1.95 Million	86,300 Added 116.62%	160,300 $2.25 Million
Q2 2023 Aug 11, 2023	BUY	$8.75 - $14.29 $227,500 - $371,540	26,000 Added 54.17%	74,000 $766,000
Q1 2023 May 12, 2023	BUY	$7.99 - $11.02 $37,553 - $51,794	4,700 Added 10.85%	48,000 $444,000
Q4 2022 Feb 13, 2023	BUY	$7.55 - $11.96 $1,510 - $2,392	200 Added 0.46%	43,300 $384,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $9.41 $3,605 - $4,705	-500 Reduced 1.15%	43,100 $359,000
Q2 2022 Aug 12, 2022	BUY	$5.12 - $8.74 $96,768 - $165,186	18,900 Added 76.52%	43,600 $357,000
Q1 2022 May 13, 2022	BUY	$5.92 - $9.73 $146,224 - $240,331	24,700 New	24,700 $215,000
Q1 2021 May 13, 2021	SELL	$17.99 - $26.96 $590,072 - $884,288	-32,800 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$17.54 - $25.43 $575,312 - $834,104	32,800 New	32,800 $591,000
Q2 2019 Aug 12, 2019	SELL	$32.75 - $40.35 $262,000 - $322,800	-8,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$35.47 - $54.55 $283,760 - $436,400	8,000 New	8,000 $296,000

Others Institutions Holding URGN

# of Institutions

142

Shares Held

41.6M

Call Options Held

91.4K

Put Options Held

42.1K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $113M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account